Literature DB >> 32130292

The APOB rs693 polymorphism impacts the lipid profile of Brazilian older adults.

E S Alves1, A D Henriques1, A C Tonet-Furioso2,3, R S Paula1, L O Gomes3, C F Moraes2,3, O T Nóbrega1,2,4.   

Abstract

The apolipoprotein B (APOB) gene contains several polymorphic sites described as risk modifiers for cardiovascular events. The objective of this study was to verify the association of the classic APOB Xba I polymorphism (rs693) with atherosclerotic risk factors in a segment of the Brazilian elderly population considering their usual dietary intake. Clinical and biochemical characteristics as well as total caloric and fat intake data were determined from 644 elderly individuals. Polymorphism analysis was performed by conventional polymerase chain reaction followed by enzyme restriction. Statistical analyses compared measures and proportions according to different APOB genotypic combinations. Statistically significant association was found between Xba I polymorphism and serum LDL, total cholesterol, and total lipid levels, with important elevations among T homozygotes compared to the other genotypes. There was homogeneity in all other parameters analyzed (including intake pattern), with a tendency for reduced levels of circulating apolipoprotein B among TT individuals. Our results pointed out that genetic variation in APOB affected the lipemic profile of elderly individuals in a context not biased by diet, generating a pattern suggestive of secretory disorder of lipoprotein particles, with possible implication in atherosclerotic risk.

Entities:  

Year:  2020        PMID: 32130292     DOI: 10.1590/1414-431X20199102

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  1 in total

1.  Lifestage Sex-Specific Genetic Effects on Metabolic Disorders in an Adult Population in Korea: The Korean Genome and Epidemiology Study.

Authors:  Young-Sang Kim; Yon Chul Park; Ja-Eun Choi; Jae-Min Park; Kunhee Han; Kwangyoon Kim; Bom-Taeck Kim; Kyung-Won Hong
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.